CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 44  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0884
LYS 10.0269
GLU 20.0165
LEU 30.0180
ARG 40.0271
CYS 50.0130
GLN 60.0089
CYS 70.0136
ILE 80.0375
LYS 90.0294
THR 100.0207
TYR 110.0214
SER 120.0268
LYS 130.0260
PRO 140.0227
PHE 150.0110
HIS 160.0040
PRO 170.0049
LYS 180.0031
PHE 190.0106
ILE 200.0117
LYS 210.0190
GLU 220.0201
LEU 230.0148
ARG 240.0144
VAL 250.0078
ILE 260.0172
GLU 270.0215
SER 280.0140
GLY 290.0130
PRO 300.0714
HIS 310.0233
CYS 320.0269
ALA 330.0614
ASN 340.0150
THR 350.0160
GLU 360.0118
ILE 370.0045
ILE 380.0137
VAL 390.0168
LYS 400.0185
LEU 410.0148
SER 420.0065
ASP 430.0265
GLY 440.0130
ARG 450.0139
GLU 460.0180
LEU 470.0167
CYS 480.0147
LEU 490.0110
ASP 500.0154
PRO 510.0174
LYS 520.0260
GLU 530.0096
ASN 540.0209
TRP 550.0111
VAL 560.0070
GLN 570.0039
ARG 580.0105
VAL 590.0070
VAL 600.0087
GLU 610.0183
LYS 620.0136
PHE 630.0126
LEU 640.0180
LYS 650.0209
ARG 660.0175
ALA 670.0247
GLU 680.0438
ASN 690.0884

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.